Stocks and Investing Stocks and Investing
Tue, December 9, 2014
Mon, December 8, 2014
Fri, December 5, 2014
Thu, December 4, 2014

Tazeen Ahmad Maintained (BCRX) at Sell with Decreased Target to $8 on, Dec 4th, 2014


Published on 2024-10-25 06:49:46 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Sell with Decreased Target from $9 to $8 on, Dec 4th, 2014.

Tazeen has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Tazeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tazeen


  • Jessica Fye of "JP Morgan" Initiated at Buy and Held Target at $20 on, Friday, August 8th, 2014
Contributing Sources